Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Work In Process: 2021-2025

Historic Work In Process for Aytu Biopharma (AYTU) over the last 5 years, with Jun 2025 value amounting to $1.4 million.

  • Aytu Biopharma's Work In Process fell 74.37% to $862,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $862,000, marking a year-over-year decrease of 74.37%. This contributed to the annual value of $1.4 million for FY2025, which is 75.88% down from last year.
  • As of FY2025, Aytu Biopharma's Work In Process stood at $1.4 million, which was down 75.88% from $5.7 million recorded in FY2024.
  • In the past 5 years, Aytu Biopharma's Work In Process ranged from a high of $5.7 million in FY2024 and a low of $1.4 million during FY2025.
  • In the last 3 years, Aytu Biopharma's Work In Process had a median value of $3.0 million in 2023 and averaged $3.4 million.
  • In the last 5 years, Aytu Biopharma's Work In Process soared by 93.67% in 2024 and then slumped by 75.88% in 2025.
  • Aytu Biopharma's Work In Process (Yearly) stood at $3.3 million in 2021, then slumped by 45.07% to $1.8 million in 2022, then surged by 60.83% to $3.0 million in 2023, then spiked by 93.67% to $5.7 million in 2024, then plummeted by 75.88% to $1.4 million in 2025.